Product Information
DIGOXIN 250 MCG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1484 per EA under NDC 00143124101. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 ug/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143124101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIGOXINApproval Type
Generic (ANDA)
FDA Application
ANDA077002FDA Approved
10/30/2007
TE Code
AB
On Market Since
10/30/2007
Pharmacological Classes
Price Statistics
The NADAC for DIGOXIN 250 MCG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 28.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1484 per EA |
|---|---|
| All-time high | $1.1823 (Mar 12, 2014) |
| All-time low | $0.1154 (Nov 28, 2013) |
| 52-week high | $0.1614 |
| 52-week low | $0.1347 |
| Median price | $0.3286 |
| Average price | $0.4451 |
| Largest weekly change | +779.3% (Dec 18, 2013) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Digoxin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cardiac Glycoside class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIGOXIN 250 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIGOXIN 250 MCG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1484 per EA (NDC 00143124101), effective Sep 30, 2026.
How has the price of DIGOXIN 250 MCG TABLET changed over time?
Over the history we have for it, the NADAC for DIGOXIN 250 MCG TABLET has risen 28.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIGOXIN 250 MCG TABLET?
Since Nov 28, 2013, the NADAC for DIGOXIN 250 MCG TABLET has ranged from a low of $0.1154 (Nov 28, 2013) to a high of $1.1823 (Mar 12, 2014), with a median of $0.3286 per EA.
Are there cheaper alternatives to DIGOXIN 250 MCG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DIGOXIN 250 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DIGOXIN 250 MCG TABLET?
DIGOXIN 250 MCG TABLET (NDC 00143124101) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.